2023-506442-24-00已完成1 期
A study to learn how PF-07817883 is taken up into the blood of healthy adults after taking tablets of study drug with varying ingredients
Pfizer Inc., Pfizer Inc.1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2023年10月13日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 12
- 试验地点
- 1
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 65+ years（65+ Years, 18-64 Years）
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Clinical Medical Lead
Scientific
Pfizer Inc.
研究点 (1)
Loading locations...
相似试验
已完成
1 期
A study to learn how BAY2927088 is taken up and handled by the body in healthy male participants2022-502771-38-00Bayer AG, Bayer AG8
招募中
1 期
Effect of SAR445611 on inflammatory responses following LPS challenge study in healthy participantsCTIS2024-511618-19-00Sanofi-Aventis Recherche & Developpement40
招募中
1 期
Investigation of safety, tolerability and pharmacokinetics of multiple doses of NNC0113-6856 in healthy participants, including a subset of healthy Japanese participantsType 2 diabetesMedDRA version: 21.1Level: LLTClassification code: 10045242Term: Type II diabetes mellitus Class: 10027433CTIS2023-503891-26-00ovo Nordisk A/S170
招募中
1 期
A Phase I Study of RO7589831 in Participants with Advanced Solid TumorsCTIS2023-503170-20-01F. Hoffmann-La Roche AG49
进行中（未招募）
1 期
A Phase I Study of RO7589831 in Participants with Advanced Solid TumorsCTIS2023-503170-20-00F. Hoffmann-La Roche AG49